Healing Chronic Wounds with DACC Technology

Purpose

The goal of this case series is to evaluate the clinical efficacy and cost effect use of DACC technology to treat chronic wounds in long term care facilities versus silver dressings. Patient’s present to the Long Term Care setting with a variety of chronic wounds. One of the challenges in treating these chronic wounds is effectively managing the bio-burden. Historically a variety of silver products have been utilized to manage bacteria with varying results. Many times silver products are used for extended periods of time without the intended outcome and as a result and increase in healthcare cost.

Materials

DACC Technology is a unique bacterial binding dressing that is coated with a fatty acid derivative (dialkycarbamoyl chloride). DACC uses a physical MOA to irreversibly bind with the bacterial cell wall through hydrophobic interaction rendering the bacteria inert and unable to move back into the wound bed.  As a result the wound can move from the inflammatory phase into the proliferative phase of wound healing.

Methods

A variety of patients with chronic wounds were followed that resided throughout the Life Care Center of America community. The patients had a variety wound types that were chronic in nature and had been treated with numerous modalities including silver products to control the bio-burden. All of the patients received a variety of DACC dressings. The patients had there dressings changed per protocol and results were documented.

Result/Conclusion

All patients that were treated with the DACC dressing showed improvement as evidenced by reduction in size, odor, and drainage. The DACC dressing successfully managed the bio-burden in all wounds and proved to be an effective alternative to traditional methods of managing bacteria in chronic wounds.